{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T14:45:43Z","timestamp":1792421143074,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T00:00:00Z","timestamp":1676851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T00:00:00Z","timestamp":1676851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2021R1A2C2011325"],"award-info":[{"award-number":["2021R1A2C2011325"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Diabetes mellitus (DM) is associated with various cardiovascular complications, including sudden cardiac arrest (SCA). Furthermore, the severity of DM, as assessed by fasting blood glucose (FBG), is associated with the risk of SCA. However, whether long-term changes in FBG influence on SCA risk remains to be determined.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This study used sequential nationwide health screening data from 2009 and 2011. FBG was measured at each health screening, and \u0394FBG was calculated as FBG in 2011\u2013FBG in 2009.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Overall, 2,801,153 people were analyzed, and the mean follow-up duration was 6.33\u00a0years. Compared with the euglycemic group (\u2212\u00a020\u2009\u2264\u2009\u0394FBG\u2009&lt;\u200920), the 20\u2009\u2264\u2009\u0394FBG\u2009&lt;\u200940, 40\u2009\u2264\u2009\u0394FBG\u2009&lt;\u2009100, and \u0394FBG\u2009\u2265\u2009100 groups had increased SCA risks of 25% (adjusted hazard ratio [HR]\u2009=\u20091.25; 95% confidence interval [CI] 1.16\u20131.35; p\u2009&lt;\u20090.001), 66% (adjusted HR\u2009=\u20091.66; 95% CI 1.49\u20131.86; p\u2009&lt;\u20090.001), and 2.9-fold (adjusted HR\u2009=\u20092.85; 95% CI 2.37\u20133.44; p\u2009&lt;\u20090.001), respectively. The association between \u0394FBG and SCA was maintained in people with DM but not in people without DM. However, sex, age, blood pressure, and presence of heart failure did not affect the association between \u0394FBG and SCA. A decrease in \u0394FBG over time was not associated with reduced risk of SCA: the adjusted HR was 1.11 (95% CI 0.98\u20131.27; p\u2009=\u20090.113) for the \u0394FBG\u2009&lt;\u2009\u201340 group and 1.12 (95% CI 1.03\u20131.22; p\u2009=\u20090.009) for the \u2212\u00a040\u2009\u2264\u2009\u2206FBG\u2009&lt;\u2009\u2212\u00a020 group.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>A long-term increase in \u0394FBG can be associated with increased risk of SCA in people with DM. However, a long-term decrease in \u0394FBG was not associated with reduced risk of SCA. Actions to prevent increase in FBG can have significant effects on public health in terms of SCA prevention.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12933-023-01764-0","type":"journal-article","created":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T14:04:20Z","timestamp":1676901860000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Long-term increase in fasting blood glucose is associated with increased risk of sudden cardiac arrest"],"prefix":"10.1186","volume":"22","author":[{"given":"Yun Gi","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Young","family":"Roh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo Hee","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyoung Seok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyongjin","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun Young","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Do","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaemin","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Il","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,20]]},"reference":[{"issue":"18","key":"1764_CR1","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa1601891","volume":"376","author":"K Kragholm","year":"2017","unstructured":"Kragholm K, Wissenberg M, Mortensen RN, Hansen SM, Malta Hansen C, Thorsteinsson K, Rajan S, Lippert F, Folke F, Gislason G, et al. Bystander efforts and 1-year outcomes in out-of-hospital cardiac arrest. N Engl J Med. 2017;376(18):1737\u201347.","journal-title":"N Engl J Med"},{"issue":"23","key":"1764_CR2","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1056\/NEJMra1802529","volume":"381","author":"WJ Brady","year":"2019","unstructured":"Brady WJ, Mattu A, Slovis CM. Lay responder care for an adult with out-of-hospital cardiac arrest. N Engl J Med. 2019;381(23):2242\u201351.","journal-title":"N Engl J Med"},{"issue":"19","key":"1764_CR3","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1016\/j.jacc.2021.03.299","volume":"77","author":"S Ricceri","year":"2021","unstructured":"Ricceri S, Salazar James W, Vu Andrew A, Vittinghoff E, Moffatt E, Tseng ZH. Factors predisposing to survival after resuscitation for sudden cardiac arrest. J Am Coll Cardiol. 2021;77(19):2353\u201362.","journal-title":"J Am Coll Cardiol"},{"key":"1764_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11071781","author":"YG Kim","year":"2022","unstructured":"Kim YG, Han K, Jeong JH, Roh SY, Choi YY, Min K, Shim J, Choi JI, Kim YH. Metabolic syndrome, gamma-glutamyl transferase, and risk of sudden cardiac death. J Clin Med. 2022. https:\/\/doi.org\/10.3390\/jcm11071781.","journal-title":"J Clin Med"},{"issue":"18","key":"1764_CR5","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1056\/NEJMoa1514204","volume":"374","author":"PJ Kudenchuk","year":"2016","unstructured":"Kudenchuk PJ, Brown SP, Daya M, Rea T, Nichol G, Morrison LJ, Leroux B, Vaillancourt C, Wittwer L, Callaway CW, et al. Amiodarone, lidocaine, or placebo in out-of-hospital cardiac arrest. N Engl J Med. 2016;374(18):1711\u201322.","journal-title":"N Engl J Med"},{"issue":"24","key":"1764_CR6","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1056\/NEJMoa2100591","volume":"384","author":"J Dankiewicz","year":"2021","unstructured":"Dankiewicz J, Cronberg T, Lilja G, Jakobsen JC, Levin H, Ullen S, Rylander C, Wise MP, Oddo M, Cariou A, et al. Hypothermia versus normothermia after out-of-hospital cardiac arrest. N Engl J Med. 2021;384(24):2283\u201394.","journal-title":"N Engl J Med"},{"key":"1764_CR7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2101909","author":"S Desch","year":"2021","unstructured":"Desch S, Freund A, Akin I, Behnes M, Preusch MR, Zelniker TA, Skurk C, Landmesser U, Graf T, Eitel I, et al. Angiography after out-of-hospital cardiac arrest without ST-segment elevation. N Engl J Med. 2021. https:\/\/doi.org\/10.1056\/NEJMoa2101909.","journal-title":"N Engl J Med"},{"issue":"5","key":"1764_CR8","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1161\/01.CIR.83.5.1832","volume":"83","author":"RO Cummins","year":"1991","unstructured":"Cummins RO, Ornato JP, Thies WH, Pepe PE. Improving survival from sudden cardiac arrest: the \u201cchain of survival\u201d concept. A statement for health professionals from the Advanced Cardiac Life Support Subcommittee and the Emergency Cardiac Care Committee, American Heart Association. Circulation. 1991;83(5):1832\u201347.","journal-title":"Circulation"},{"issue":"10124","key":"1764_CR9","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/S0140-6736(18)30316-7","volume":"391","author":"MEH Ong","year":"2018","unstructured":"Ong MEH, Perkins GD, Cariou A. Out-of-hospital cardiac arrest: prehospital management. Lancet. 2018;391(10124):980\u20138.","journal-title":"Lancet"},{"issue":"1","key":"1764_CR10","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/S0196-0644(99)70415-4","volume":"33","author":"IG Stiell","year":"1999","unstructured":"Stiell IG, Wells GA, DeMaio VJ, Spaite DW, Field BJ, Munkley DP, Lyver MB, Luinstra LG, Ward R. Modifiable factors associated with improved cardiac arrest survival in a multicenter basic life support\/defibrillation system: OPALS study phase I results. Ann Emerg Med. 1999;33(1):44\u201350.","journal-title":"Ann Emerg Med"},{"issue":"1","key":"1764_CR11","doi-asserted-by":"publisher","first-page":"12307","DOI":"10.1038\/s41598-022-16543-2","volume":"12","author":"YG Kim","year":"2022","unstructured":"Kim YG, Roh SY, Han K-D, Jeong JH, Choi YY, Min K, Shim J, Choi J-I, Kim Y-H. Hypertension and diabetes including their earlier stage are associated with increased risk of sudden cardiac arrest. Sci Rep. 2022;12(1):12307.","journal-title":"Sci Rep"},{"issue":"24","key":"1764_CR12","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","volume":"358","author":"HC Gerstein","year":"2008","unstructured":"Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH Jr, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358(24):2545\u201359.","journal-title":"N Engl J Med"},{"issue":"24","key":"1764_CR13","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","volume":"358","author":"A Patel","year":"2008","unstructured":"Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358(24):2560\u201372.","journal-title":"N Engl J Med"},{"issue":"15","key":"1764_CR14","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","volume":"359","author":"RR Holman","year":"2008","unstructured":"Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HAW. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(15):1577\u201389.","journal-title":"N Engl J Med"},{"issue":"22","key":"1764_CR15","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","volume":"373","author":"B Zinman","year":"2015","unstructured":"Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, Mattheus M, Devins T, Johansen OE, Woerle HJ. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. 2015;373(22):2117\u201328.","journal-title":"N Engl J Med"},{"issue":"4","key":"1764_CR16","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1603827","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS. Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2016;375(4):311\u201322.","journal-title":"N Engl J Med"},{"issue":"5","key":"1764_CR17","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1161\/HYPERTENSIONAHA.120.16513","volume":"77","author":"YG Kim","year":"2021","unstructured":"Kim YG, Han K-D, Kim DY, Choi YY, Choi HY, Roh S-Y, Shim J, Kim JS, Choi J-I, Kim Y-H. Different influence of blood pressure on new-onset atrial fibrillation in pre-and postmenopausal women: a nationwide population-based study. Hypertension. 2021;77(5):1500\u20139.","journal-title":"Hypertension"},{"key":"1764_CR18","doi-asserted-by":"publisher","DOI":"10.1177\/2047487320915664","author":"YG Kim","year":"2020","unstructured":"Kim YG, Han KD, Choi JI, Choi YY, Choi HY, Boo KY, Kim DY, Lee KN, Shim J, Kim JS, et al. Non-genetic risk factors for atrial fibrillation are equally important in both young and old age: a nationwide population-based study. Eur J Prev Cardiol. 2020. https:\/\/doi.org\/10.1177\/2047487320915664.","journal-title":"Eur J Prev Cardiol"},{"issue":"1","key":"1764_CR19","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12933-019-0932-z","volume":"18","author":"YG Kim","year":"2019","unstructured":"Kim YG, Han KD, Choi JI, Boo KY, Kim DY, Oh SK, Lee KN, Shim J, Kim JS, Kim YH. The impact of body weight and diabetes on new-onset atrial fibrillation: a nationwide population based study. Cardiovasc Diabetol. 2019;18(1):128.","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"1764_CR20","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3904\/kjim.2020.481","volume":"36","author":"YG Kim","year":"2021","unstructured":"Kim YG, Oh SK, Choi HY, Choi JI. Inherited arrhythmia syndrome predisposing to sudden cardiac death. Korean J Intern Med. 2021;36(3):527\u201338.","journal-title":"Korean J Intern Med"},{"issue":"20","key":"1764_CR21","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1093\/eurheartj\/ehi376","volume":"26","author":"X Jouven","year":"2005","unstructured":"Jouven X, Lema\u00eetre RN, Rea TD, Sotoodehnia N, Empana J-P, Siscovick DS. Diabetes, glucose level, and risk of sudden cardiac death. Eur Heart J. 2005;26(20):2142\u20137.","journal-title":"Eur Heart J"},{"issue":"9324","key":"1764_CR22","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1016\/S0140-6736(02)09089-X","volume":"359","author":"A Norhammar","year":"2002","unstructured":"Norhammar A, Tenerz \u00c5, Nilsson G, Hamsten A, Efend\u00edc S, Ryd\u00e9n L, Malmberg K. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. The Lancet. 2002;359(9324):2140\u20134.","journal-title":"The Lancet"},{"issue":"1","key":"1764_CR23","doi-asserted-by":"publisher","first-page":"201","DOI":"10.2337\/diacare.27.1.201","volume":"27","author":"RJ Stevens","year":"2004","unstructured":"Stevens RJ, Coleman RL, Adler AI, Stratton IM, Matthews DR, Holman RR. Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66. Diabetes Care. 2004;27(1):201\u20137.","journal-title":"Diabetes Care"},{"issue":"7","key":"1764_CR24","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1093\/eurheartj\/ehi199","volume":"26","author":"K Malmberg","year":"2005","unstructured":"Malmberg K, Ryd\u00e9n L, Wedel H, Birkeland K, Bootsma A, Dickstein K, Efendic S, Fisher M, Hamsten A, Herlitz J. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J. 2005;26(7):650\u201361.","journal-title":"Eur Heart J"},{"issue":"24","key":"1764_CR25","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","volume":"358","author":"Group AtCCRiDS","year":"2008","unstructured":"Group AtCCRiDS. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358(24):2545\u201359.","journal-title":"N Engl J Med"},{"issue":"24","key":"1764_CR26","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","volume":"358","author":"Group AC","year":"2008","unstructured":"Group AC. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358(24):2560\u201372.","journal-title":"N Engl J Med"},{"key":"1764_CR27","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso SP, Bain SC, Consoli A, Eliaschewitz FG, J\u00f3dar E, Leiter LA, Lingvay I, Rosenstock J, Seufert J, Warren ML. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med. 2016;375:1834\u201344.","journal-title":"N Engl J Med"},{"key":"1764_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109031","volume":"179","author":"TI Hariyanto","year":"2021","unstructured":"Hariyanto TI, Intan D, Hananto JE, Putri C, Kurniawan A. Pre-admission glucagon-like peptide-1 receptor agonist (GLP-1RA) and mortality from coronavirus disease 2019 (Covid-19): a systematic review, meta-analysis, and meta-regression. Diabetes Res Clin Pract. 2021;179: 109031.","journal-title":"Diabetes Res Clin Pract"},{"issue":"14","key":"1764_CR29","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1056\/NEJMoa1307684","volume":"369","author":"BM Scirica","year":"2013","unstructured":"Scirica BM, Bhatt DL, Braunwald E, Steg PG, Davidson J, Hirshberg B, Ohman P, Frederich R, Wiviott SD, Hoffman EB. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. N Engl J Med. 2013;369(14):1317\u201326.","journal-title":"N Engl J Med"},{"issue":"3","key":"1764_CR30","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1056\/NEJMoa1501352","volume":"373","author":"JB Green","year":"2015","unstructured":"Green JB, Bethel MA, Armstrong PW, Buse JB, Engel SS, Garg J, Josse R, Kaufman KD, Koglin J, Korn S. Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2015;373(3):232\u201342.","journal-title":"N Engl J Med"},{"key":"1764_CR31","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1056\/NEJMoa1305889","volume":"369","author":"WB White","year":"2013","unstructured":"White WB, Cannon CP, Heller SR, Nissen SE, Bergenstal RM, Bakris GL, Perez AT, Fleck PR, Mehta CR, Kupfer S. Alogliptin after acute coronary syndrome in patients with type 2 diabetes. N Engl J Med. 2013;369:1327\u201335.","journal-title":"N Engl J Med"},{"issue":"1","key":"1764_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-016-0001-8","volume":"6","author":"C-S Lee","year":"2016","unstructured":"Lee C-S, Kim YG, Cho H-J, Park J, Jeong H, Lee S-E, Lee S-P, Kang H-J, Kim H-S. Dipeptidyl peptidase-4 inhibitor increases vascular leakage in retina through VE-cadherin phosphorylation. Sci Rep. 2016;6(1):1\u201316.","journal-title":"Sci Rep"},{"issue":"18","key":"1764_CR33","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1161\/CIRCULATIONAHA.114.010389","volume":"130","author":"BM Scirica","year":"2014","unstructured":"Scirica BM, Braunwald E, Raz I, Cavender MA, Morrow DA, Jarolim P, Udell JA, Mosenzon O, Im K, Umez-Eronini AA. Heart failure, saxagliptin, and diabetes mellitus: observations from the SAVOR-TIMI 53 randomized trial. Circulation. 2014;130(18):1579\u201388.","journal-title":"Circulation"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-023-01764-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-023-01764-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-023-01764-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T14:05:23Z","timestamp":1676901923000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-023-01764-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,20]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1764"],"URL":"https:\/\/doi.org\/10.1186\/s12933-023-01764-0","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,20]]},"assertion":[{"value":"23 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The current study was approved by the Institutional Review Board of Korea University Medicine Anam Hospital and official review committee of the K-NHIS. Considering the retrospective nature of this study, the requirement for written informed consent was waived. The ethical guidelines of the 2013 Declaration of Helsinki and legal medical regulations of Republic of Korea were strictly undertaken throughout the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no competing interests and no relationships with industry.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38"}}